By clicking “Accept,” you agree to the use of cookies and similar technologies on your device as set forth in our Cookie Policy and our Privacy Policy. Please note that certain cookies are essential for this website to function properly and do not require user consent to be deployed.

Drink?

The New Science of Alcohol and Health

Contributors

By Professor David Nutt

Formats and Prices

Price

$18.99

Price

$24.99 CAD

This item is a preorder. Your payment method will be charged immediately, and the product is expected to ship on or around December 22, 2020. This date is subject to change due to shipping delays beyond our control.

From a world-renowned authority on alcohol abuse, a book that exposes the side effects drinking imposes on our overall health–and how we can moderate our consumption.

From after-work happy hour to a nightly glass of wine, we’re used to thinking of alcohol as a normal part of our daily lives. In Drink?, neuropharmacology professor David Nutt takes a fascinating, science-based look at drinking to unpack why we should reconsider our favorite pastime.

Nutt addresses topics such as hormones, mental health, fertility, and addiction, explaining how alcohol effects us even after it leaves our systems. With accessible language, Nutt ensures that readers recognize why alcohol can have such a negative influence on our bodies and our society. Drink?  gives readers clear, evidence-based facts to help them make the most informed choices about their alcohol intake.

  • "[Drink?] offers an abundance of medical research without judgement."
    Library Journal
  • "Professor Nutt both knows what he’s talking about, and isn’t afraid to say it. And Drink? is a very good book for anyone interested in what alcohol does to us, both mentally and physically, in both good and bad ways."
    Club Soda

On Sale
Dec 22, 2020
Page Count
256 pages
Publisher
Balance
ISBN-13
9780306923845

Professor David Nutt

About the Author

David Nutt is Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences at Imperial College, London.

After completing his medical training at Guy's Hospital London, continuing in neurology to MRCP, he went on to his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol University, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008 where he leads a similar group with a particular focus on brain imaging especially PET.

David is currently Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. previously he has been President of the European College of Neuropsychopharmacology (ECNP), the British Neuroscience Association (BNA) and the British Association of Psychopharmacology (BAP). In addition, he is a Fellow of the Royal Colleges of Physicians and of Psychiatrists and a Fellow of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders Courses and a member of the International Centre for Science in Drug Policy. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary.

Previously he has been a member and then Chair of the Advisory Committee on the Misuse of Drugs (ACMD – 1998-2009), a member of the HEFCE/NHS Senior Lecturer Selection Panel and of the MRC Neuroscience Board. Other previous national contributions include serving as the medical expert on the Independent Inquiry into the Misuse of Drugs Act (2000 Runciman report), and membership of the Committee on Safety of Medicines, the Committee on NHS drugs and the Ministry of Defence Science Advisory Board. He was the clinical scientific lead on the 2004/5 UK Government Foresight initiative "Brain science, addiction and drugs" that provided a 25-year vision for this area of science and public policy.

David broadcasts widely to the general public both on radio and television including BBC science and public affairs programmes on therapeutic as well as illicit drugs, their harms and their classification. He also lecturers widely to the public as well as to the scientific and medical communities; he has presented three time at the Cheltenham Science Festival and several times for Café Scientifiques.

Learn more about this author